Coeptis Therapeutics Holdings Inc. (COEP)

NASDAQ

$--

(--)

Pre-Market

Coeptis Therapeutics Holdings Inc. (COEP) Live Price Chart

Last updated: ⁦2026-10-21 08:31:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Coeptis Therapeutics Holdings Inc. (COEP) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Coeptis Therapeutics Holdings Inc. (COEP) Pre-Market Stock Price

Coeptis Therapeutics Holdings Inc. (COEP) is trading at $-- in pre-market trading as of --, -- from the previous close of $--

Pre-market trading shows how investors are pricing COEP before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.

Coeptis Therapeutics Holdings Inc. (COEP) 7-Day Stock Price Change

Over the past seven days, Coeptis Therapeutics Holdings Inc. (COEP) moved from $12.82 to $16.40, representing a gain of 27.93% ($3.58).

The stock traded between $12.54 and $17.27 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 90.36 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

What is Coeptis Therapeutics Holdings Inc. (COEP)?

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Coeptis Therapeutics Holdings Inc. Information

Industry	FINANCE SERVICES
Employees	6
Exchange	NASDAQ
Company Website	https://www.coeptistx.com

How to Buy Coeptis Therapeutics Holdings Inc. (COEP) Stock on MEXC

Eligible investors can buy real shares of Coeptis Therapeutics Holdings Inc. (COEP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for COEP and Place Your Order

Open the RealStocks trading page and search for COEP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Coeptis Therapeutics Holdings Inc. (COEP) stock price today?

Coeptis Therapeutics Holdings Inc. (COEP) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is COEP stock going up or down today?

As of --, COEP is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is COEP pre-market price?

As of --, COEP is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is COEP after-hours price?

As of --, COEP is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is COEP stock trading now?

COEP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does COEP sit relative to its 52-week high and low?

Over the past 52 weeks, COEP has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Coeptis Therapeutics Holdings Inc. in?

Coeptis Therapeutics Holdings Inc. (COEP) operates in the FINANCE SERVICES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Coeptis Therapeutics Holdings Inc.'s market capitalization and where is it listed?

Coeptis Therapeutics Holdings Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is COEP valued in terms of P/E ratio and EPS?

COEP trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Coeptis Therapeutics Holdings Inc. pay a dividend?

Coeptis Therapeutics Holdings Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.